Track NAD+ in Peptimes
NAD+ (nicotinamide adenine dinucleotide), also called nadide or coenzyme I, is a dinucleotide, not a peptide. (Source: FDA's substance registry (GSRS).)
Is NAD+ FDA-approved?
No. NAD+ isn't FDA-approved: Drugs@FDA lists no application with NAD+ (nadide) as an active ingredient.
NAD+
Also: NAD, nicotinamide adenine dinucleotide, nadide, coenzyme I
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- SubcutaneousOther
- Updated
- 25 Oct 2026
US regulatory status
FDA status
Not FDA-Approved. Drugs@FDA lists no application with NAD+ (nadide) as an active ingredient.
Source: Drugs@FDA, checked 25 Oct 2026
How to track it in Peptimes
Add NAD+ in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: subcutaneous or Other. Choose the one that matches each dose.
- Logging: the amount you took, the route and how you feel.
- Injection sites: subcutaneous doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Doses logged as Other skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell NAD+ or any other compound.
More sources
- FDA, Global Substance Registration System, Nadide, checked 25 Oct 2026: the names nadide, NAD, nicotinamide adenine dinucleotide and coenzyme I.
Related pages
Coming soon to the App Store
See planned pricing